Browse > Article

Development of Animal Model for Diabetes and Hyperlipidemia  

Oh Seung Hyun (서울대학교 수의과대학 발생유전학실)
Roh Kyung-Jin (서울대학교 수의과대학 발생유전학실)
Park In-Sun (인하대학교 의과대학 해부학교실)
Min Bon Hong (고려대학교 의과대학 약리학교실)
Doo Ho-Kyung (경희대학교 한의과대학)
Ahn Se Young (경희대학교 한의과대학)
Kim Yong Suk (경희대학교 한의과대학)
Seong Je Kyung (서울대학교 수의과대학 발생유전학실)
Publication Information
Environmental Analysis Health and Toxicology / v.19, no.3, 2004 , pp. 287-294 More about this Journal
Abstract
Diabetic complication is one of major risk factors leading to vascular disease such as atherosclerosis, stroke, coronary heart disease and etc. Several factors affecting the acceleration of diabetic vascular complication have been known such as hypertension, hyperlipidemia, immune complex and genetic factors. To screen and develop new therapeutics agents for diabetic vascular complication, it is strongly needed to develop animal models for diabetic complications. However in rodents models, diabetic complications is not well developed. Furthermore to assess the possibility of new therapeutics for diabetic vascular complications, diabetic animal models which have the risk factors of diabetic complications is needed. We aim to develop and establish an diabetic animal model which have diabetic complications with hyperlipidemia which is one of risk factors for diabetic complications. We induced insulin -dependent diabetes by intra. venous injection of streptozotocin (35 mg/kg/day) in RICO rats which is a spontaneous animal model for hyperlipidemia. Our models (STZ RICO) showed hyperglycemia, persistent high level of plasma cholesterol and triglyceridemia with severe diabetic renal changes until 28 weeks after induction of diabetes. STZ-RICO rats could be used for the evaluations of newly developed diabetic drugs.
Keywords
diabetes; hyperlipidemia; RICO; animal model;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Abrass CK and Cohen AH. Accelerated glomerulosclerosis in diabetic rats with immunocomplex injury. Diabetes, 1987; 36: 1246-1253   DOI   ScienceOn
2 Brown D.M, Steffes M.W, Thibert P, Azar. S and Maver SM. Glomerular manifestations of diabetes in the BB rat. Metabolism, 32(7) (Suppl. 1): 1983; 131-135   DOI
3 Hajri T, Ferezou J, Laruelle C and Lutton C. Crilvastatin, a new 3-hydroxy-3-methylglutaryl-coenzyme A red-uctase inhibitor, inhibits cholesterol absorption in gene-tically hypercholesterolemic rats. Eur J Pharmacol. 1995; 286(2): 131-136   DOI   ScienceOn
4 Riottot M, Olivier P, Huet A, Caboche JJ, Parquet M, Khallou J and Lutton C. Hypolipidemic effects of beta-cyclodextrin in the hamster and in the genetically hyper-cholesterolemic Rico rat. Lipids. 1993; 28(3): 181-188   DOI   ScienceOn
5 Lutton C. Anatomical heterogeneity of the intestinal mucosa and cholesterol homeostasis. A review of studies with normal and genetically hypercholesterolemic (RICO) Rat. Digestion. 1996; 57(1): 1-10
6 Luoma H, Metsa-Ketela T, Jauhiainen M, Alakuijala P, Korhonen A and Nevalainen T. Effects of dietary fluoride and magnesium supplements on cyclic adeno-sine monophosphate (cAMP), calcium and magnesium levels in aorta of genetically hypercholesterolaemic RICO rats. Scand J Clin Lab Invest. 1997; 57(5): 421- 425   DOI   ScienceOn
7 Fantappie S, Maggi FM, Cancellieri M, Bosisio E, Malavasi B and Catapano AL. Effect of bezafibrate on plasma lipid in a strain of genetically hypercholesterolemic RICO rats. Pharmacol Res. 1989; 21(Suppl 1): 109-110
8 Lutton C, Ouguerram K, Sauvage M and Magot T. Turnover of [14C] sucrose HDL and uptake by organs in the normal or genetically hypercholesterolemic (RICO) rat using a constant infusion method. Reprod Nutr Dev. 1990; 30(1): 97-101   DOI   PUBMED   ScienceOn
9 Tsi D and Tan BK. Effects of celery extract and 3-N-butylphthalide on lipid levels in genetically hypercho-lesterolaemic (RICO) rats. Clin Exp Pharmacol Physiol. 1996; 23(3): 214-217   DOI
10 Luoma H, Alakuijala P, Korhonen A, Nevalainen T, Kuronen M and Jauhiainen M. Serum lipoprotein levels in genetically hypercholesterolaemic RICO rats: effects of a high-sucrose-cholesterol diet without or with altered magnesium and fluoride content. Scand J Clin Lab Invest. 1995; 55(6): 495-503   DOI   ScienceOn
11 Lutton C, Milliat F, Feurgard C, Mathe D, Aigueperse J and Meslin JC. Regional cholesterol synthesis in the intestinal mucosa of the genetically hypercholestero-laemic RICO rat: kinetic study following whole-body gamma-irradiation. Int J Radiat Biol. 1999; 75(2): 175-181   DOI   PUBMED   ScienceOn
12 Cardona-Sanclemente LE, Sultan F and Griglio S. Characterization and quantification of apolipoprotein E in the genetically hypercholesterolemic rat (RICO). Rev Esp Fisiol. 1996: 52(1): 15-22
13 이태희와 최영길. 당뇨병성혈관합병증의 역학. 당뇨병성혈관합병증, 서울, 고려의학. 1993: 21-30
14 Felgines C, Serougne C, Mathe D, Mazur A and Lutton C. Effect of simvastatin treatment on plasma apolipoproteins and hepatic apolipoprotein mRNA levels in the genetically hypercholesterolemic rat (RICO). Life Sci. 1994; 54(5): 361-367   DOI   ScienceOn
15 Ouguerram K, Magot T and Lutton C. Metabolism of plasma lipoproteins in the genetically hypercholes-terolemic rat (RICO). Metabolism. 1996; 45(1): 4-11   DOI   ScienceOn
16 $\phi$sterby R, Parving HH, Hommel E, Jorgensen HE and Lokkegaard H. Glomerular structure and function in diabetic nephropathy. Early to advanced stages. Dia-betes, 1990;39: 1057-1062
17 대한당뇨병학회, 당뇨병의 역학. '당뇨병학' 대한당뇨병학회저, 고려의학, 서울. 1992, 11-24
18 Yugarani T, Tan BK and Das NP. The effects of tannic acid on serum and liver lipids of RAIF and RICO rats fed on high fat diet. Comp Biochem Physiol Comp Physiol. 1993; 104(2): 339-343   DOI
19 Sultan F, Cardona-Sanclemente LE, Lagrange D, Lutton C and Griglio S. Lipoprotein lipase and hepatic lipase activities in a hypercholesterolaemic (RICO) strain of rat. Effect of dietary cholesterol. Biochem J. 1990; 1; 266(2): 349-353   DOI
20 Cardona-Sanclemente LE, Ferezou J and Lutton C. Cholesterol metabolism in the genetically hypercholesterolemic (RICO) rat. II. A study of plasma lipoproteins and effect of dietary cholesterol. Biochim Biophys Acta. 1988; 960(3): 382-389   DOI
21 류진숙, 이기업. 연령 및 이환기간에 따른 당뇨병 만성 혈관합병증의 유병율과 연관성, 당뇨병, 1992; 16(2) : 145-150
22 Milliat F, Serougne C, Gripois D and Lutton C. Effects of in-sulin deficiency on lipoproteins and their hepatic receptors in Rico rats. CR Acad Sci III. 1998; 321(12): 999-1006   DOI   ScienceOn
23 김용수 방병기. 우리나라 투석요법의 현황. 대한신장학회지, 1991; 11: 187-199
24 Ramos OL. Diabetes mellitus and hypertension. 1988; 11 (Supp1.1):I-14-I-18
25 Lutton C and Champarnaud G. Cholesterol synthesis and high density lipoprotein uptake are regulated inde-pendently in rat small intestinal epithelium. Gut. 1994; 35(3): 343-346
26 Somani P, Singh HP, Saini RK and Robinovitch A. Strepto-zotocin-induced diabetes in the spontaneously hyper-tensive rat. Metabolism, 1979; 28: 1075-1077   DOI   ScienceOn
27 Brown DM and Andres GA. Kidney complications. Diabetes, 1982; 31(Suppl. 1): 71-81   DOI
28 Felgines C, Serougne C, Mazur A, Ferezou J, Lutton C and Rayssiguier Y. Hepatic apolipoprotein and LDL rece-ptor gene expression in the genetically hypercholes-terolemic (RICO) rat. Atherosclerosis. 1995; 117(1): 15-24   DOI   ScienceOn
29 Luoma H, Jauhiainen M, Alakuijala P and Nevalainen T. Seven weeks feeding of magnesium and fluoride modi-fies plasma lipids of hypercholesterolaemic rats in late growth phase. Magnes Res. 1998; 11(4): 271-282
30 Ouguerram K, Magot T and Lutton C. Metabolism of intes-tinal triglyceride-rich lipoproteins in the genetically hypercholesterolemic rat. Atherosclerosis. 1992; 93(3): 201-208   DOI   ScienceOn
31 Mortimer BC, Beveridge DJ, Phan CT, Lutton C and Redgrave TG. The diurnal rhythms of cholesterol metabolism and plasma clearance of model chylomi-crons: comparison of normal and genetically hyperchol-esterolemic rats (RICO). Comp Biochem Physiol A Mol Integr Physiol. 1998; 120(4): 671-680   DOI   ScienceOn
32 Lutton C. [The RICO rat (genetically hypercholesteremic): a good model for testing a food substance or a drug specific for a key enzyme of cholesterol metabolism]. Reprod Nutr Dev. 1999; 39(4): 481-495   DOI   ScienceOn
33 성제경, 오양석. 고혈압 모델 동물 (SHR)에서 streptozotocin으로 유발한 인슐린 의존형 당뇨병에 관한 연구. 한국실험동물학회지, 1992; 8(2): 161-174
34 Cooper ME and Allen TJ. Accelerated progression of diabetic nephropathy in the spontaneously hypertensive streptozotocin diabetic rat. Clin Exp Pharmacol Physiol, 1986; 13: 655-662   DOI   PUBMED